GENZYME CORP Depreciation and Amortization
GENZYME CORP reported Depreciation and Amortization of $495.44 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2011-03-01
- GENZYME CORP depreciation, depletion and amortization for the quarter ending 2010-12-31 was $124.43M, a 2.03% decline year-over-year.
- GENZYME CORP depreciation, depletion and amortization for the quarter ending 2010-09-30 was $124.97M, a 3.42% increase year-over-year.
- GENZYME CORP depreciation, depletion and amortization for the quarter ending 2010-06-30 was $123.35M, a 12.59% increase year-over-year.
- GENZYME CORP depreciation, depletion and amortization for the quarter ending 2010-03-31 was $122.69M, a 23.98% increase year-over-year.
- GENZYME CORP depreciation, depletion and amortization for fiscal 2010 was $495.44M, a 8.56% increase from fiscal 2009.
- GENZYME CORP depreciation, depletion and amortization for fiscal 2009 was $456.36M, a 21.81% increase from fiscal 2008.
- GENZYME CORP depreciation, depletion and amortization for fiscal 2008 was $374.66M.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2010-12-31 | $124.43M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $249.41M derived: sum of 2 quarters · filed 2011-03-01 | $372.75M derived: sum of 3 quarters · filed 2011-03-01 | $495.44M 10-K · filed 2011-03-01 |
| 2010-09-30 | $124.97M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $248.32M derived: sum of 2 quarters · filed 2010-11-09 | $371.01M 10-Q · filed 2010-11-09 | $498.01M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | $123.35M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $246.04M 10-Q/A · filed 2010-09-07 | $373.04M derived: sum of 3 quarters · filed 2011-03-01 | $493.88M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | $122.69M 10-Q/A · filed 2010-05-11 | $249.69M derived: sum of 2 quarters · filed 2011-03-01 | $370.54M derived: sum of 3 quarters · filed 2011-03-01 | $480.09M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | $127.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $247.85M derived: sum of 2 quarters · filed 2011-03-01 | $357.41M derived: sum of 3 quarters · filed 2011-03-01 | $456.36M 10-K · filed 2011-03-01 |
| 2009-09-30 | $120.84M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $230.40M derived: sum of 2 quarters · filed 2010-11-09 | $329.36M 10-Q · filed 2010-11-09 | $427.98M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | $109.56M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $208.51M 10-Q/A · filed 2010-09-07 | $307.14M derived: sum of 3 quarters · filed 2011-03-01 | $400.06M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | $98.96M 10-Q/A · filed 2010-05-11 | $197.58M derived: sum of 2 quarters · filed 2011-03-01 | $290.50M derived: sum of 3 quarters · filed 2011-03-01 | |
| 2008-12-31 | $98.62M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $191.54M derived: sum of 2 quarters · filed 2011-03-01 | $374.66M 10-K · filed 2011-03-01 | |
| 2008-09-30 | $92.92M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-02 | $276.04M 10-Q · filed 2009-11-02 | ||
| 2008-06-30 | $183.12M 10-Q/A · filed 2009-09-04 | |||
| 2007-12-31 | $338.20M 8-K · filed 2010-06-14 |